Hydroxocobalamin rescue from nimodipine-induced refractory vasoplegia

Clin Neurol Neurosurg. 2021 Dec:211:107026. doi: 10.1016/j.clineuro.2021.107026. Epub 2021 Nov 10.

Authors

Thomas M Cooper¹, Justin W Shewmaker², Joseph R Blunck³

Affiliations

¹ Saint Luke's Hospital - Department of Neurocritical Care, 4401 Wornall Rd, Kansas City, MO 64111, USA.
² Saint Luke's Hospital - Department of Pharmacy, 4401 Wornall Rd, Kansas City, MO 64111, USA.
³ Saint Luke's Hospital - Department of Pharmacy, 4401 Wornall Rd, Kansas City, MO 64111, USA. Electronic address: [email protected].

PMID: 34781218
DOI: 10.1016/j.clineuro.2021.107026

No abstract available

Publication types

Case Reports

MeSH terms

Aged
Female
Hematinics / therapeutic use*
Humans
Hydroxocobalamin / therapeutic use*
Nimodipine / adverse effects*
Vasodilator Agents / adverse effects*
Vasoplegia / chemically induced*
Vasoplegia / drug therapy*

Substances

Hematinics
Vasodilator Agents
Nimodipine
Hydroxocobalamin